by newsworm | Jan 8, 2025 | Pharma, Zydus
Zydus Lifesciences, a Ahmedabad-based company, has partnered with CVS Caremark to add three tablets to its formulary starting January 1, 2025. The products, Zituvio, Zituvimet, and Zituvimet XR, contain active ingredients sitagliptin and metformin hydrochloride and... by newsworm | Jan 8, 2025 | Pharma
GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This move aligns with GenScript’s commitment to fulfilling its social... by newsworm | Jan 8, 2025 | Pharma, Zydus
Zydus Lifesciences, a leading Indian pharmaceutical company, has made a significant breakthrough in the development of new compounds to treat dengue virus infection. The company’s research team has identified novel compounds that have shown promising results in... by newsworm | Jan 8, 2025 | Mankind, Pharma
Complete Circle Capital’s wealth management arm has raised $3 million in its inaugural fund raise from investor groups led by Rajeev and Arjun Juneja, from Mankind Pharma’s promoter family office, and Narinder Bajaj, director and chairman of Mitutoyo South... by newsworm | Jan 8, 2025 | Pharma
Henan Lingrui Pharmaceutical (SHSE:600285) is a Chinese company that specializes in the research, development, and production of pharmaceuticals. The company has been gaining attention recently due to its strong financial performance and potential for future growth.... by newsworm | Jan 7, 2025 | Pharma, Zydus
Zydus Lifesciences Ltd has announced an agreement with CVS Caremark to add three diabetes treatments, Zituvio, Zituvimet, and Zituvimet XR, to CVS’s template formulary. The products, which contain active ingredients sitagliptin and metformin hydrochloride, are... by newsworm | Jan 7, 2025 | Pharma, Zydus
Zydus Cadila has signed an agreement with CVS Caremark, a leading healthcare company, to add three medications to its template formulary. The medications are Zituvio, Zituvimet, and Zituvimet XR, which contain the active ingredients sitagliptin and sitagliptin and... by newsworm | Jan 7, 2025 | Pharma
The article identifies the top 5 commercial biotech buyout candidates, including Day One Biopharmaceuticals (NASDAQ: DAWN). Here’s a summary: Day One Biopharmaceuticals (NASDAQ: DAWN): Develops treatments for rare genetic diseases, with a pipeline of candidates... by newsworm | Jan 7, 2025 | Pharma
In 2024, pharmaceutical companies made a surge of deals with Chinese biotechs, focusing on antibody-drug conjugates, according to New York-based investment bank Jefferies. This is due to China’s efforts to revamp its life sciences policy, including bolstering... by newsworm | Jan 7, 2025 | Pharma, Zydus
Zydus Lifesciences Ltd., a global healthcare company, has announced an agreement with CVS Caremark to add three of its diabetes medications, Zituvio, Zituvimet, and Zituvimet XR, to CVS’s template formulary. The medications, which contain sitagliptin and...